A Stability-Indicating UPLC Method for the Determination of Potential Impurities and Its Mass by a New QDa Mass Detector in Daclatasvir Drug Used to Treat Hepatitis C Infection-Reference-Cited by-同舟云学术

A Stability-Indicating UPLC Method for the Determination of Potential Impurities and Its Mass by a New QDa Mass Detector in Daclatasvir Drug Used to Treat Hepatitis C Infection

Published:2018-08-28 Issue:1 Volume:57 Page:44-53
ISSN:0021-9665
Container-title:Journal of Chromatographic Science
language:en
Short-container-title:

Author:

Jagadabi Varaprasad¹²,Nagendra kumar P V¹,Mahesh Kasthuri¹,Pamidi Srinivasu²,Ramaprasad L A²,Nagaraju D²

Affiliation:

1. Department of Chemistry, School of Technology, GITAM University, Hyderabad Campus, Hyderabad, Telangana, India

2. Analytical R&D, Hetero Labs Ltd, Hyderabad, Telangana, India

Publisher

Oxford University Press (OUP)

Subject

General Medicine,Analytical Chemistry

Link

http://academic.oup.com/chromsci/article-pdf/57/1/44/27176759/bmy079.pdf

Reference34 articles.

1. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect;Gao;Nature,2010

2. Peginterferon alfa-2a plus ribavirin for chronic hepatitis c virus infection;Fried;The New England Journal of Medicine,2002

3. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;Hadziyannis;Annals of Internal Medicine,2004

4. The results of phase III clinical trials with telaprevir and boceprevir presented at the liver meeting 2010: a new standard of care for hepatitis c virus genotype 1 infection, but with issues still pending;Pawlotsky;Gastroenterology,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality by Design-driven Analytical Method: A Quality Risk Management-Based Liquid Chromatography Method for Daclatasvir and Characterization of its Putative Degradants by LC-MS/MS;Current Pharmaceutical Analysis;2024-03

2. Monitoring stability indicating impurities and aldehyde content in lipid nanoparticle raw material and formulated drugs;Journal of Chromatography B;2024-01

3. Voltammetric determination of daclatasvir dihydrochloride at bimetallic Ag/Co nanoparticles modified carbon paste electrode;Microchemical Journal;2023-08

4. Principles and Applications of Ultra-High-Performance Liquid Chromatography;High Performance Liquid Chromatography - Recent Advances and Applications;2023-05-24

5. DACLATASVIR DIHYDROCHLORIDE MICROSPHERES, PROCESS PARAMETERS FOR ENHANCED PERMEABILITY AND LIVER TARGETING;Asian Journal of Pharmaceutical and Clinical Research;2022-12-07